Finland· FI-REL-REL54746

Mircera

A methoxy polyethylene glycol-epoetin beta product containing methoxy polyethylene glycol-epoetin beta, registered in Finland by Orifarm Oy. The same ATC class is registered in 12 of our 19 countries.

ATC B03XA03

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedMirceraATCB03XA03REGISTER NO.FI-REL-REL54746PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Methoxy polyethylene glycol-epoetin beta is registered in 12 of 19 countries.

Countries holding a registration under ATC B03XA03 (methoxy polyethylene glycol-epoetin beta), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Methoxy polyethylene glycol-epoetin beta · ATC B03XA03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methoxy polyethylene glycol-epoetin beta costs, country by country.

Normalised to the WHO defined daily dose (4 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Methoxy polyethylene glycol-epoetin beta · price per daily dose (4 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$10.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Methoxy polyethylene glycol-epoetin beta
Manufacturer
Orifarm Oy
Country
Finland (FI)
ATC code
B03XA03
ATC class
Methoxy polyethylene glycol-epoetin beta
Defined daily dose
4 mcg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d95f7b5f-8526-4e33-a48f-a9e5a1b10e76
GET /v1/drugs/d95f7b5f-8526-4e33-a48f-a9e5a1b10e76?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "4",
  "form": "injektioneste, liuos, esitäytetty ruisku",
  "route": "Ihon alle",
  "ddd_unit": "mcg",
  "strength": "120 mikrog / 0.3 ml",
  "atc_label": "metoksipolyetyleeniglykoliepoetiini beeta",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/07/400/020",
  "fimea_rel_id": "REL54746",
  "authorised_at": "2019-03-13"
}

See everything about methoxy polyethylene glycol-epoetin beta.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.